Fulgent Genetics (FLGT) Other Non Operating Income (2023 - 2026)

Fulgent Genetics has disclosed Other Non Operating Income across 4 years of filings, most recently posting $38000.0 for Q2 2026.

• In Q2 2026, Other Non Operating Income fell 17.39% year-over-year to $38000.0; the TTM figure through Jun 2026 stood at -$4.0 million (down 698.35% YoY), while the FY2025 annual figure was -$3.9 million, down 797.5% from the prior year.
• Other Non Operating Income came in at $38000.0 for Q2 2026 at Fulgent Genetics, up from $10000.0 in the prior quarter.
• In the past five years, Other Non Operating Income ranged from a high of $544000.0 in Q3 2024 to a low of -$4.0 million in Q4 2025.
• Average Other Non Operating Income over 4 years is -$257500.0, with a median of $10500.0 recorded in 2024.
• The largest YoY upside for Other Non Operating Income was 855.56% in 2025 against a maximum downside of 57557.14% in 2025.
• Over 4 years, Other Non Operating Income stood at -$22000.0 in 2023, then soared by 131.82% to $7000.0 in 2024, then plunged by 57557.14% to -$4.0 million in 2025, then jumped by 100.94% to $38000.0 in 2026.
• Per Business Quant data, the three most recent Other Non Operating Income figures were $38000.0 in Q2 2026, $10000.0 in Q1 2026, and -$4.0 million in Q4 2025.